All practice questions

8270 questions

Question 3361Question →

A 24-year-old woman comes to the primary care clinic reporting feeling "constantly on edge" for the past 3 months. She states she has been worrying excessively about her academic performance, her finances, and her parents' health. The patient reports experiencing restlessness, muscle tension in her neck and shoulders, and difficulty concentrating on her studies. These symptoms began 3 months ago when she moved to a new city to start a rigorous graduate program. She acknowledges that the transition has been very stressful, and her academic performance has declined because she is so distracted by her worries. She denies any history of trauma, panic attacks, or periods of elevated mood. Her physical examination and laboratory studies, including thyroid-stimulating hormone, are within normal limits. Which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Adjustment disorder with anxiety

Answer

Adjustment disorder with anxiety
The correct answer is adjustment disorder with anxiety. This patient presents with excessive worry, restlessness, muscle tension, and impaired concentration that began shortly after a major life stressor (moving to a new city for graduate school). Crucially, these symptoms have caused significant functional impairment (academic decline). Adjustment disorder is diagnosed when emotional or behavioral symptoms develop within 3 months of an identifiable stressor and cause marked distress or functional impairment, provided the symptoms do not meet the criteria for another specific psychiatric disorder. Because her symptoms have only been present for 3 months, she does not yet meet the 6-month duration requirement for generalized anxiety disorder.

Step-by-Step Solution

1
Identify the primary symptoms and their duration.
The patient has excessive worry, restlessness, muscle tension, and poor concentration lasting for exactly 3 months.
Establishing the timeline and symptom profile is necessary to differentiate between various anxiety disorders.
2
Identify any triggering events and functional impact.
The symptoms began concurrently with moving for graduate school (an identifiable psychosocial stressor) and have caused an academic decline (functional impairment).
The presence of a stressor and functional impairment are key criteria for distinguishing pathology from a normal stress response.
3
Apply DSM-5 diagnostic criteria to rule out other disorders.
Generalized anxiety disorder requires 6 months of symptoms. Acute stress disorder requires a life-threatening trauma. Therefore, the presentation best fits an adjustment disorder.
Adjustment disorder is often a diagnosis of exclusion when symptoms triggered by a stressor do not meet the full duration or symptom criteria for another specific mental disorder.

Key Concept

Adjustment disorder is diagnosed when significant emotional or behavioral symptoms, leading to distress or functional impairment, develop within 3 months of a psychosocial stressor and do not meet criteria for another psychiatric disorder.
Estimated Time:1m 15s
Question 3362Question →

A 32-year-old woman presents to the outpatient clinic with a 2-month history of severely depressed mood. She reports sleeping up to 14 hours a day, an increased appetite with a 5-kg (11-lb) weight gain, and a frequent sensation that her arms and legs are "made of lead." She states that she briefly feels better when her friends visit, but her low mood quickly returns. She has no prior psychiatric history and has never been treated for depression. She tearfully requests an antidepressant medication so she can return to her job as an accountant. Her vital signs and physical examination are unremarkable. Laboratory studies reveal a thyroid-stimulating hormone (TSH) level of 1.5 mU/L (normal: 0.4-4.0 mU/L) and a free T4 at the lower limit of normal. A urine toxicology screen is negative. The physician diagnoses a major depressive episode with atypical features and considers initiating pharmacotherapy. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Elicit a history of periods of elevated mood, impulsivity, and decreased need for sleep

Answer

The correct answer is to elicit a history of periods of elevated mood, impulsivity, and decreased need for sleep.
The correct next step is to screen the patient for a lifetime history of manic or hypomanic episodes. While this patient is currently experiencing a major depressive episode, atypical features (such as hypersomnia, weight gain, leaden paralysis, and mood reactivity) are particularly common in the depressive phase of bipolar disorder. Universal screening for bipolar disorder is required before initiating any antidepressant monotherapy. Failing to do so can lead to the inappropriate administration of an antidepressant (e.g., an SSRI), which carries a significant risk of inducing a manic switch or rapid cycling in patients with underlying bipolar disorder.

Step-by-Step Solution

1
Identify the current clinical syndrome.
The patient meets the criteria for a major depressive episode with atypical features (hypersomnia, hyperphagia, leaden paralysis, mood reactivity).
Recognizing the symptom cluster is required to establish the baseline diagnosis.
2
Determine the necessary safety and diagnostic checks prior to initiating antidepressant treatment.
The physician must screen for a history of mania or hypomania.
Antidepressant monotherapy can precipitate a manic episode (manic switch) in patients with undiagnosed bipolar disorder. Atypical depressive features specifically have a high correlation with bipolar depression.
3
Evaluate the provided options against standard psychiatric management guidelines.
Screening for manic/hypomanic symptoms is the only safe and appropriate next step before writing a prescription.
All other options involve inappropriate prescribing practices, contraindicated combinations, or incorrect application of diagnostic timelines.

Key Concept

Screening for bipolar disorder before initiating antidepressant monotherapy
Question 3363Question →

A 38-year-old man, a self-employed clock repairman, presents to a primary care clinic for a physical examination required to renew his commercial driver's license. He has not interacted with the healthcare system in over a decade. During the interview, the patient is guarded and reluctant to answer questions regarding his medical history. When asked about his living situation, he becomes irritable, demanding to know why the physician is "prying into my personal life" and questioning whether the clinic intends to share his information with government agencies to revoke his license. The patient's brother, who is in the waiting room, privately informs the nurse that the patient has always been "highly suspicious" of others since his early twenties. The brother notes that the patient frequently accuses his clients of trying to defraud him and has completely cut off contact with several family members because he suspects they are secretly plotting to ruin his business. The patient has never experienced hallucinations, his speech is goal-directed and organized, and he does not hold magical or bizarre beliefs. Which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Paranoid personality disorder

Answer

Paranoid personality disorder
The correct answer is paranoid personality disorder. This condition is characterized by a pervasive and long-standing pattern of distrust and suspiciousness of others. Patients frequently interpret the motives of others as malevolent, bear grudges, and suspect that others are exploiting or deceiving them without sufficient basis. This patient's lifelong history (since his early twenties) of suspecting government agencies, clients, and family members of plotting against him perfectly aligns with this diagnosis. Crucially, he does not exhibit fixed, bizarre delusions or hallucinations, which distinguishes his condition from primary psychotic disorders.

Step-by-Step Solution

1
Analyze the patient's primary symptoms and their duration.
The patient exhibits pervasive distrust and suspiciousness across multiple contexts (clinic, clients, family) starting in early adulthood.
Establishing the core symptom cluster and its timeline differentiates personality disorders from acute psychotic episodes.
2
Evaluate for the presence of true psychotic features.
There are no hallucinations, disorganized speech, magical thinking, or fixed delusions localized to a single false belief.
The absence of these features rules out primary psychotic disorders like schizophrenia or delusional disorder.
3
Differentiate among Cluster A personality disorders.
The primary presentation is active suspicion and distrust, rather than emotional detachment (schizoid) or odd, magical beliefs (schizotypal).
Cluster A disorders share a genetic relationship with schizophrenia but have distinct clinical presentations.

Key Concept

Paranoid personality disorder is characterized by a pervasive, lifelong pattern of distrust and suspiciousness of others, interpreting their motives as malevolent, without the presence of fixed delusions or other psychotic features.
Question 3364Question →

A primary care physician is evaluating a 71-year-old retired mechanic who is accompanied by his son. The son reports that over the past 14 months, his father has exhibited progressive short-term memory loss, missed several bill payments, and recently struggled to recall the names of his grandchildren. The patient feels he is "doing just fine" and is mildly annoyed by the visit. Vital signs are normal, and the neurological examination is nonfocal. Arrange the following diagnostic and management steps in the most appropriate chronological sequence for evaluating and managing this patient's suspected major neurocognitive disorder, from initial clinical assessment to definitive management.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with objective cognitive screening, followed by screening for reversible metabolic causes, obtaining structural neuroimaging, considering specialized biomarker testing if indicated, and concluding with a comprehensive management and safety plan.
The standard of care for evaluating insidious cognitive decline follows a stepwise approach designed to minimize unnecessary testing while safely ruling out reversible etiologies. The clinician must first objectively confirm the cognitive deficit (Step 1). Subsequently, easily reversible systemic, endocrine, and metabolic causes are excluded via basic laboratory testing (Step 2). Once metabolic causes are ruled out, structural neuroimaging is obtained to identify vascular changes, space-occupying lesions, or distinct neurodegenerative atrophy patterns (Step 3). If the diagnosis remains equivocal, advanced functional imaging or cerebrospinal fluid biomarker testing may be considered (Step 4). Finally, once a diagnosis is established, a comprehensive management plan addressing safety, pharmacology, and long-term care is implemented (Step 5).

Step-by-Step Solution

1
Confirm cognitive impairment.
Use of the Montreal Cognitive Assessment or Mini-Mental State Examination.
Before pursuing a costly and potentially invasive diagnostic workup, the presence and severity of cognitive deficits must be objectively established.
2
Rule out reversible metabolic or systemic causes.
Ordering vitamin B12, TSH, comprehensive metabolic panel, and complete blood count.
Hypothyroidism, vitamin B12 deficiency, and various metabolic derangements can present as pseudodementia and are easily treatable if identified early.
3
Evaluate for structural intracranial pathology.
Performing a non-contrast brain MRI (or CT).
Structural imaging rules out space-occupying lesions, normal pressure hydrocephalus, and vascular dementia while evaluating for characteristic neurodegenerative atrophy patterns.
4
Differentiate complex or atypical etiologies.
Considering FDG-PET, amyloid PET, or lumbar puncture.
If the presentation is atypical (e.g., early-onset) or the distinction between Alzheimer disease and frontotemporal dementia is unclear, specialized biomarkers are utilized.
5
Establish long-term management and safety parameters.
Discussing driving cessation, advance directives, and prescribing medications like cholinesterase inhibitors.
Appropriate medical and social management is tailored based on the definitive diagnosis reached through the preceding diagnostic cascade.

Key Concept

Diagnostic Algorithm for Major Neurocognitive Disorders
Question 3365Question →

A 24-year-old woman is evaluated in the outpatient psychiatry clinic. She reports a 4-week history of severe sadness, loss of interest in her usual activities, hypersomnia, and low energy. She is diagnosed with major depressive disorder and prescribed escitalopram. The physician counsels her extensively on what to expect during the course of her treatment. Arrange the following clinical events in the typical chronological order of their occurrence after initiating this pharmacotherapy, from earliest to latest.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The typical chronological sequence is: onset of gastrointestinal side effects (hours to days), improvement in neurovegetative symptoms like energy and sleep (1-2 weeks), improvement in subjective mood (4-6 weeks), and finally, achievement of maximal therapeutic benefit (8-12 weeks).
The timeline of selective serotonin reuptake inhibitor (SSRI) response follows a distinct and predictable sequence. Adverse effects, such as gastrointestinal upset (nausea, diarrhea) or headache, occur almost immediately (within hours to days) due to acute serotonin reuptake inhibition. The earliest therapeutic benefit is observed in neurovegetative symptoms (sleep, energy, appetite), which typically begin to improve at 1 to 2 weeks. Core affective symptoms, including depressed mood and anhedonia, take longer and typically begin to improve at 4 to 6 weeks. Finally, maximal therapeutic benefit and potential remission may require 8 to 12 weeks of continuous treatment.

Step-by-Step Solution

1
Identify the event with the earliest onset after initiating an SSRI.
Gastrointestinal adverse effects.
These occur almost immediately (within hours to days) due to acute stimulation of serotonin receptors.
2
Identify the earliest therapeutic response.
Improvement in neurovegetative symptoms.
Sleep, appetite, and energy levels typically improve first, around weeks 1 to 2 of treatment.
3
Determine when the core mood symptoms begin to respond.
Reduction in subjective sadness.
Affective symptoms require 4 to 6 weeks to show noticeable improvement.
4
Identify the final event in the treatment timeline.
Maximum therapeutic benefit.
Full remission or maximal response often takes 8 to 12 weeks of continuous therapy.

Key Concept

Timeline of SSRI therapeutic response and side effects
Question 3366Question →

A 5252-year-old woman comes to the surgical clinic for evaluation of a newly discovered lump in her left breast. She first noticed the mass 22 weeks ago. 66 months prior, she underwent a bilateral reduction mammoplasty. She has no personal or family history of breast disease. On physical examination, there is a 33-cm, firm, irregular mass in the lower outer quadrant of the left breast. The skin overlying the mass shows mild dimpling. There is no axillary lymphadenopathy. Diagnostic mammography reveals a localized area of increased density with coarse, irregular calcifications and spiculated margins. A core needle biopsy of the mass is performed. Which of the following is the most likely histopathologic finding in this patient's breast lesion?

Show answer & explanation

Answer: Lipid-laden macrophages and multinucleated giant cells surrounding necrotic adipocytes

Answer

Lipid-laden macrophages and multinucleated giant cells surrounding necrotic adipocytes
The correct answer identifies the histologic features of fat necrosis. This patient's presentation of a firm, irregular breast mass with skin dimpling and a spiculated mammographic appearance is classically suspicious for breast cancer. However, her recent history of a reduction mammoplasty points strongly to fat necrosis as the underlying cause. Breast trauma (including surgery, seatbelt injury, or blunt trauma) damages adipocytes, releasing lipids that incite a localized inflammatory response. Over time, this leads to fibrosis, which can pull on Cooper's ligaments (causing skin dimpling) and create a spiculated mass with coarse calcifications on mammography. A core needle biopsy is necessary to definitively rule out malignancy; in fat necrosis, it typically reveals lipid-laden macrophages (foam cells), multinucleated giant cells, and anucleate (necrotic) adipocytes surrounded by fibrous tissue.

Step-by-Step Solution

1
Analyze the patient's history and risk factors.
The patient is a 52-year-old woman with a recent history of significant breast surgery (reduction mammoplasty 6 months ago).
Recent breast surgery or trauma is a major risk factor for developing localized tissue injury and subsequent fat necrosis.
2
Evaluate the clinical and radiographic findings.
Clinical exam shows a firm, irregular mass with skin dimpling. Mammography shows a spiculated mass with coarse calcifications.
These findings are highly suspicious for malignancy, but are also the classic presentation of fat necrosis, which is known to mimic breast cancer.
3
Determine the expected histopathology based on the diagnosis of fat necrosis.
The biopsy will show lipid-laden macrophages (foam cells), multinucleated giant cells, and anucleate adipocytes.
Fat necrosis is an inflammatory response to damaged adipose tissue, leading to macrophage infiltration to clear the lipid debris, followed by fibrosis and calcification.

Key Concept

Fat necrosis of the breast is a benign condition resulting from local trauma or surgery that can clinically and radiographically mimic breast cancer. Diagnosis is confirmed by biopsy showing lipid-laden macrophages and giant cells.
Question 3367Question →

A 26-year-old26\text{-year-old} female graduate student presents to the outpatient psychiatry clinic accompanied by her roommate due to worsening isolation and depression. For the past 3 weeks3 \text{ weeks}, the patient has stayed in her room, slept up to 14 hours14 \text{ hours} a day, and consumed large amounts of junk food, leading to a 4 kg4 \text{ kg} (8.8 lb8.8 \text{ lb}) weight gain. She tells the physician, "I am a failure and I hear a voice whispering that I should just give up." Her roommate mentions that the patient has been taking an over-the-counter herbal supplement, St. John's wort, for the past 2 months2 \text{ months} to "help with her mood," but it has not provided any relief.

Review of her psychiatric history reveals that 2 years2 \text{ years} ago, she had a distinct 6-day6\text{-day} period where she felt "incredibly energized," slept only 3 hours3 \text{ hours} per night, and simultaneously wrote three term papers while serving as the president of a student club. She did not require hospitalization during that time, and her overall functioning was arguably enhanced.

Her vital signs and physical examination are normal. Laboratory studies, including a TSH of 4.5 \muU/mL4.5 \text{ \mu U/mL} (normal: 0.5−5.0 \muU/mL0.5 - 5.0 \text{ \mu U/mL}) and a free T4 of 0.9 ng/dL0.9 \text{ ng/dL} (normal: 0.8−1.8 ng/dL0.8 - 1.8 \text{ ng/dL}), are unremarkable.

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Discontinue St. John's wort and initiate quetiapine

Answer

Discontinue St. John's wort and initiate quetiapine
The correct action is to discontinue St. John's wort and initiate quetiapine. This patient presents with a major depressive episode (hypersomnia, weight gain, depressed mood) accompanied by mood-congruent psychotic features (hearing a whispering voice). However, her history of a 6-day episode of elevated energy, decreased need for sleep, and hyper-productivity that did not cause severe impairment represents a past hypomanic episode. Therefore, her correct diagnosis is Bipolar II disorder. The first-line treatment for bipolar depression includes atypical antipsychotics such as quetiapine or lurasidone, which effectively target both the depressive and psychotic symptoms. St. John's wort should be discontinued because it is ineffective for severe bipolar depression and acts as a potent CYP3A4 inducer, which would decrease the serum concentration of quetiapine.

Step-by-Step Solution

1
Synthesize the patient's current presentation.
The patient is experiencing a major depressive episode (depressed mood, hypersomnia, weight gain) with mood-congruent psychotic features (auditory hallucinations) lasting 3 weeks.
Establishing the current syndrome is necessary to guide acute management.
2
Evaluate the patient's psychiatric history for previous mood episodes.
The patient has a history of a distinct 6-day period of elevated energy, decreased need for sleep, and hyper-productivity without severe impairment.
A past hypomanic episode changes the diagnosis from Major Depressive Disorder to Bipolar II Disorder, fundamentally altering the treatment algorithm.
3
Review laboratory results to rule out secondary causes.
TSH and Free T4 are within normal limits.
Medical etiologies such as hypothyroidism must be excluded before finalizing a primary psychiatric diagnosis.
4
Select the appropriate pharmacotherapy and manage current medications.
Initiate quetiapine to treat the bipolar depression and psychosis, and discontinue St. John's wort.
Antidepressant monotherapy is contraindicated in bipolar disorder. Quetiapine treats both the mood and psychotic symptoms. St. John's wort is a CYP3A4 inducer (which lowers quetiapine levels) and carries serotonergic risks.

Key Concept

Bipolar depression with psychotic features requires treatment with agents that target both mood and psychosis (e.g., quetiapine, lurasidone), while avoiding antidepressant monotherapy due to the risk of a manic switch.
Estimated Time:2m 0s
Question 3368Question →

A 16-year-old girl is hospitalized for severe malnutrition secondary to anorexia nervosa, restricting subtype. Her body mass index (BMI) is 13.2 kg/m213.2 \text{ kg/m}^2. The medical team plans to initiate careful nutritional rehabilitation but is acutely concerned about a potentially fatal metabolic complication characterized by severe electrolyte derangements. Arrange the following pathophysiological steps of this syndrome in the correct chronological sequence, starting from the initial dietary trigger to the ultimate clinical manifestations.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence begins with the reintroduction of carbohydrates, followed by an abrupt insulin surge, leading to the intracellular shift of electrolytes. This causes profound hypophosphatemia and decreased ATP synthesis, ultimately culminating in life-threatening clinical complications.
Refeeding syndrome pathogenesis follows a strict sequence: Carbohydrate intake triggers massive insulin release. Insulin drives phosphate, potassium, and magnesium into cells. The resulting intravascular hypophosphatemia impairs cellular ATP production, leading to widespread cardiopulmonary and neurologic failure.

Step-by-Step Solution

1
Identify the clinical complication being described in the vignette.
The scenario describes refeeding syndrome in a severely malnourished patient with anorexia nervosa.
Patients with a very low BMI are at high risk for rapid, life-threatening metabolic derangements when feeding is restarted.
2
Determine the initial physiological trigger of the syndrome.
Reintroduction of carbohydrates is the very first step in the sequence.
Carbohydrates provide the glucose load that forcibly shifts the body out of its starvation-adapted catabolic state.
3
Identify the hormonal response to the carbohydrate load.
An abrupt surge in endogenous insulin secretion occurs.
Insulin is quickly released by the pancreas to manage the sudden influx of serum glucose and promote cellular anabolism.
4
Determine the immediate cellular effect of the insulin surge.
Rapid intracellular shifting of phosphate, potassium, and magnesium.
Insulin directly drives glucose and these crucial electrolytes from the serum into the intracellular space.
5
Identify the metabolic consequence of this rapid electrolyte shift.
Profound serum hypophosphatemia and decreased ATP synthesis.
Phosphate is depleted from the serum, severely limiting the generation of ATP, which is essential for cellular energy.
6
Determine the final clinical outcome of the profound energy depletion.
Onset of clinical complications like heart failure, arrhythmias, or seizures.
Target organs fail due to the severe lack of ATP and the arrhythmogenic effects of the combined electrolyte deficits.

Key Concept

Refeeding syndrome is a fatal complication of nutritional rehabilitation in severe malnutrition, fundamentally driven by an insulin surge that causes intracellular shifts of phosphate, potassium, and magnesium, resulting in profound ATP depletion and subsequent multiorgan failure.
Estimated Time:1m 30s
Question 3369Question →

Which psychiatric diagnosis or behavioral characterization best corresponds to each of the following patient scenarios?

Click a left item, then click its matching right item

Items

A 35-year-old paralegal reports persistent, migrating abdominal pain and severe fatigue for eight months. Despite multiple negative endoscopies and CT scans, she spends several hours each night researching potential undiagnosed malignancies and frequently changes physicians.
A 42-year-old accountant has a six-month history of intense fear regarding pancreatic adenocarcinoma following a relative's recent death. He reports occasional mild dyspepsia, has completely normal diagnostic workups, yet insists on monthly abdominal ultrasounds to ensure nothing was missed.
A 29-year-old phlebotomist is admitted with polymicrobial bacteremia involving skin flora. Intravenous antibiotics are started, but blood cultures repeatedly remain positive. A search of her hospital room reveals concealed non-sterile syringes. She has no pending lawsuits or disability claims.
A 31-year-old warehouse worker reports bilateral lower extremity paralysis following a minor slip at work. Complete neurological examination and spinal MRI are unremarkable. He is actively suing his employer for permanent disability compensation and becomes hostile when discharged.

Matches

Show answer & explanation

Answer

The scenarios represent Somatic symptom disorder, Illness anxiety disorder, Factitious disorder imposed on self, and Malingering, respectively.
Correct matching distinguishes the somatic spectrum by evaluating the prominence of physical symptoms (Somatic symptom vs. Illness anxiety) and the motivation for deceptive behaviors (primary gain in Factitious disorder vs. secondary gain in Malingering).

Step-by-Step Solution

1
Evaluate symptom severity and health-related behaviors for unconscious disorders.
The paralegal has prominent somatic symptoms and excessive thoughts about them (Somatic symptom disorder), whereas the accountant has minimal symptoms but extreme anxiety about acquiring a disease (Illness anxiety disorder).
Differentiates between Somatic symptom disorder and Illness anxiety disorder based on the physical symptom burden.
2
Assess for evidence of deception or intentional symptom fabrication.
Both the phlebotomist and the warehouse worker exhibit clear signs of feigned or self-induced illness, ruling out unconscious disorders like conversion disorder.
Identifies intentionality as the key driver of the clinical presentation.
3
Determine the underlying motivation for deceptive behavior.
The phlebotomist seeks the sick role (primary gain), indicating Factitious disorder, while the warehouse worker seeks financial compensation (secondary gain), indicating Malingering.
Differentiates between Factitious disorder and Malingering based on the presence of external rewards.

Key Concept

Differential diagnosis of somatic symptom and related disorders based on symptom severity, symptom intentionality, and underlying motivation.
Question 3370Question →

Match each of the following distinct clinical presentations to the most likely psychiatric medication-induced emergency or movement disorder.

Click a left item, then click its matching right item

Items

Sudden onset of sustained, involuntary muscle contractions, such as torticollis or oculogyric crisis, shortly after receiving intramuscular haloperidol.
Gradual development of hyperthermia, extreme generalized 'lead-pipe' muscle rigidity, autonomic instability, and elevated creatine kinase after increasing a fluphenazine dose.
Rapid onset of altered mental status, diaphoresis, hyperreflexia, and prominent lower extremity clonus in a patient taking citalopram and tramadol.
Gradual emergence of repetitive, involuntary, choreoathetoid movements of the face, mouth, and tongue after five years of uninterrupted risperidone therapy.
Development of a distressing subjective sense of inner restlessness and a compelling urge to pace the room constantly, two weeks after starting aripiprazole.

Matches

Show answer & explanation

Answer

Match the specific clinical features and timeline of symptom onset to their respective psychiatric medication-induced emergencies and adverse effects.
Each clinical scenario contains pathognomonic features for a specific medication-induced adverse effect. Acute dystonia involves sudden sustained muscle contractions. NMS presents with lead-pipe rigidity and hyperthermia. Serotonin syndrome features hyperreflexia and clonus. Tardive dyskinesia involves delayed-onset choreoathetoid movements. Akathisia is characterized by severe restlessness.

Step-by-Step Solution

1
Analyze the onset timeframe and specific neuromuscular findings in each clinical scenario.
Identified the hallmarks: sudden muscle contraction (acute dystonia), 'lead-pipe' rigidity and hyperthermia (NMS), hyperreflexia and clonus (Serotonin syndrome), late-onset choreoathetoid movements (Tardive dyskinesia), and subjective/objective restlessness (Akathisia).
Differentiating these emergencies relies primarily on the physical exam findings and the symptom timeline relative to medication exposure.
2
Differentiate between the two major life-threatening toxidromes (NMS and Serotonin Syndrome).
Confirmed that the presentation with lead-pipe rigidity matches NMS, whereas the presentation with hyperreflexia and clonus matches Serotonin Syndrome.
These two syndromes are frequently confused due to shared features of hyperthermia and autonomic instability, but their neuromuscular manifestations are opposite.

Key Concept

Distinguishing characteristics of psychiatric medication-induced emergencies and movement disorders
Question 3371Question →

Match each pediatric neurodevelopmental and behavioral clinical vignette with the primary neuropharmacological mechanism of action of the most appropriate targeted pharmacotherapy.

Click a left item, then click its matching right item

Items

An 8-year-old boy is brought to the clinic for severe impulsivity and behavioral outbursts at school. He has a history of multiple motor and vocal tics. A non-stimulant medication is selected to manage his hyperactivity because it has also demonstrated efficacy in reducing the severity of his tics.
A 16-year-old male requires pharmacological treatment for newly diagnosed attention-deficit/hyperactivity disorder. He has a recent history of cannabis use disorder. His parents explicitly request a non-controlled medication with minimal potential for abuse or diversion.
A 6-year-old boy with autism spectrum disorder exhibits severe, refractory irritability, characterized by extreme tantrums and self-injurious head-banging. A psychotropic agent known for a lower risk of inducing hyperprolactinemia compared to other drugs in its class is initiated.
A 7-year-old boy with attention-deficit/hyperactivity disorder, combined type, struggles with profound inattention leading to academic failure. He has no psychiatric comorbidities and a normal cardiovascular evaluation. The most efficacious, first-line pharmacological agent (a Schedule II controlled substance) is prescribed.

Matches

Show answer & explanation

Answer

The vignettes correctly map to alpha-2 agonism for the patient with tics, selective norepinephrine reuptake inhibition for the patient with substance use risk, partial D2 agonism for the patient with autism and irritability, and DAT/NET blockade for the patient with uncomplicated ADHD.
Each vignette requires a highly specific medication based on comorbidities: tics warrant an alpha-2 agonist, substance use history necessitates a selective norepinephrine reuptake inhibitor, autism with irritability and a desire for lower prolactin risk points to a partial D2 agonist, and uncomplicated severe ADHD requires a stimulant (reuptake blocker of dopamine and norepinephrine).

Step-by-Step Solution

1
Evaluate each patient's comorbidities and side effect sensitivities to determine the most appropriate drug class.
The patient with tics needs an alpha-2 agonist; the patient with substance use needs atomoxetine; the patient with autism needs an atypical antipsychotic like aripiprazole; the uncomplicated ADHD patient needs a stimulant.
Clinical guidelines dictate specific pharmacological choices based on a patient's unique clinical profile and risk factors.
2
Map the identified drug classes to their primary neuropharmacological mechanisms of action.
Alpha-2 agonists match central alpha-2 adrenergic receptor agonism; atomoxetine matches selective presynaptic norepinephrine transporter inhibition; aripiprazole matches partial D2 and 5-HT1A agonism; stimulants match presynaptic dopamine and norepinephrine reuptake blockade.
This confirms the correct scientific rationale for the selected treatments.

Key Concept

The selection of psychopharmacotherapy in pediatric neurodevelopmental disorders relies on matching specific drug mechanisms (e.g., alpha-2 agonism, specific transporter blockade) to the patient's symptom profile and comorbid conditions.
Question 3372Question →

A 72-year-old woman is seen by the surgical team on the fifth day following a right total hip arthroplasty. She complains of new, progressive aching pain in her right thigh and calf that began the previous evening. Her temperature is 38.3°C (100.9°F), blood pressure is 135/85 mm Hg, pulse is 96/min, and respiratory rate is 14/min. Pulse oximetry shows 98% on room air. Physical examination reveals asymmetric edema of the right lower extremity from the mid-thigh down to the ankle, along with localized tenderness over the posterior calf. The surgical incision over the lateral hip is well-approximated with no erythema, warmth, or discharge. Cardiopulmonary examination is unremarkable. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Perform compression ultrasonography of the right lower extremity

Answer

Perform compression ultrasonography of the right lower extremity
The patient's clinical presentation of unilateral lower extremity edema, calf tenderness, and low-grade fever on postoperative day 5 following major orthopedic surgery is highly suspicious for a deep vein thrombosis (DVT). DVT represents the 'Walking' component of the classic '5 Ws' of postoperative fever and typically occurs between days 4 and 6. The most appropriate initial step in evaluating a suspected DVT is compression ultrasonography of the affected extremity. This noninvasive test is highly sensitive and specific for detecting proximal venous thrombosis.

Step-by-Step Solution

1
Identify the primary clinical problem.
The patient is on postoperative day 5 after major orthopedic surgery and presents with a new-onset low-grade fever, tachycardia, and unilateral lower extremity pain and swelling.
Recognizing the timing and specific physical findings is essential to formulating a differential diagnosis for postoperative fever.
2
Correlate the findings with the '5 Ws' of postoperative fever.
The presentation strongly aligns with 'Walking' (deep vein thrombosis), which typically manifests around postoperative days 4 to 6 with unilateral leg edema and can cause a mild fever.
Connecting the clinical signs to common timeline-based postoperative complications prevents unnecessary diagnostic testing for unrelated conditions.
3
Determine the best initial diagnostic step.
Compression ultrasonography of the lower extremity is selected.
It is the standard, noninvasive, and most appropriate first test to confirm or rule out a deep vein thrombosis.

Key Concept

Postoperative fever etiology and deep vein thrombosis diagnosis
Question 3373Question →

Accompanied by her roommate, a 22-year-old female university student is evaluated at the student health center for progressive social withdrawal over the past month. The patient reports pervasive sadness, sleeping up to 14 hours daily, and an inability to concentrate on her coursework. The roommate mentions that two years prior, the patient had a distinct two-week period where she painted her entire apartment overnight, slept only 2 hours a night without feeling tired, and exhibited pressured speech, which culminated in an emergency department visit. Currently, the patient's vital signs are within normal limits. Physical examination shows no abnormalities. Mental status examination reveals a tearful young woman with psychomotor retardation and a restricted affect. She denies active suicidal ideation, homicidal ideation, or psychotic symptoms. She explicitly requests that her parents not be contacted regarding her evaluation. Laboratory results, including a comprehensive metabolic panel and thyroid-stimulating hormone levels, are normal. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Initiate quetiapine

Answer

The most appropriate next step in management is to initiate quetiapine.
The patient's current presentation of pervasive sadness, hypersomnia, and psychomotor retardation is consistent with a major depressive episode. However, her history of a distinct two-week period characterized by a decreased need for sleep, increased goal-directed activity, and pressured speech indicates a prior manic episode. Therefore, her correct diagnosis is bipolar I disorder, currently in a depressed episode. The most appropriate next step in management is the initiation of an atypical antipsychotic with proven efficacy for acute bipolar depression. Quetiapine is an FDA-approved, first-line pharmacological treatment for this condition.

Step-by-Step Solution

1
Analyze the patient's current symptoms and past psychiatric history.
The patient is experiencing a major depressive episode but has a clear history of a manic episode (decreased need for sleep, impulsivity, pressured speech).
Accurate identification of both current and past affective episodes is required to differentiate unipolar depression from bipolar disorder.
2
Formulate a diagnosis based on the clinical presentation.
The presence of a manic episode combined with the current depressive symptoms confirms a diagnosis of bipolar I disorder, currently in a depressed episode.
The diagnosis dictates the appropriate pharmacological class and highlights treatments that are contraindicated.
3
Determine the most appropriate pharmacological treatment for the current episode.
First-line treatment for acute bipolar depression includes agents like quetiapine, lurasidone, or lithium.
These medications effectively target depressive symptoms without significantly increasing the risk of a manic switch.
4
Evaluate the ethical constraints regarding the patient's request.
Since the patient is a competent adult without active suicidal or homicidal ideation, her confidentiality must be maintained.
Physicians must respect adult patients' autonomy and confidentiality unless there is an imminent threat of severe harm to the patient or a third party.

Key Concept

Treatment of acute bipolar depression requires mood stabilizers or specific second-generation antipsychotics (e.g., quetiapine, lurasidone); antidepressant monotherapy is contraindicated due to the risk of inducing a manic switch. Additionally, adult patient confidentiality must be maintained in the absence of imminent danger.
Estimated Time:1m 30s
Question 3374Question →

A 76-year-old retired architect is brought to the clinic by his son. Over the past 88 months, the patient has experienced a progressive decline in his cognitive abilities. His son notes that the patient's alertness fluctuates significantly from day to day; he sometimes stares blankly for several minutes during conversations. The patient also frequently reports seeing unfamiliar children playing in his living room, though he is not distressed by their presence. His medical history includes major depressive disorder, for which he has taken fluoxetine for 55 years. Vital signs are within normal limits. Neurological examination reveals a resting tremor in the left hand, symmetric rigidity, and a slow, shuffling gait. The Montreal Cognitive Assessment (MoCA) score is 19/3019/30. Laboratory studies show:

Thyroid-stimulating hormone (TSH): 2.4 \muU/mL2.4 \text{ \mu U/mL} (normal: 0.4−4.0 \muU/mL0.4-4.0 \text{ \mu U/mL})
Free thyroxine (T4): 1.3 ng/dL1.3 \text{ ng/dL} (normal: 0.9−2.4 ng/dL0.9-2.4 \text{ ng/dL})

The son is overwhelmed by the recent changes and demands that his father be admitted to a locked psychiatric facility immediately. However, the patient's previously executed advance directive designates his wife as the healthcare proxy and expresses a clear preference for home-based care.

Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Initiate rivastigmine therapy

Answer

The most appropriate next step is to initiate rivastigmine therapy.
This patient's clinical presentation—progressive cognitive decline, marked fluctuations in alertness, well-formed visual hallucinations, and spontaneous parkinsonism—is highly characteristic of major neurocognitive disorder with Lewy bodies (LBD). Cholinesterase inhibitors, such as rivastigmine, donepezil, or galantamine, are the first-line pharmacological treatment to manage the cognitive and behavioral symptoms of LBD. They effectively improve hallucinations, stabilize fluctuating cognition, and carry a lower risk of exacerbating motor symptoms compared to antipsychotics.

Step-by-Step Solution

1
Analyze the clinical presentation and timeline.
The patient has an 8-month history of progressive cognitive decline, marked fluctuations in alertness, well-formed visual hallucinations, and spontaneous parkinsonism (resting tremor, rigidity, shuffling gait).
Identifying the classic clinical triad establishes the diagnosis of Major Neurocognitive Disorder with Lewy bodies (LBD).
2
Evaluate the laboratory results and ethical context.
TSH and free T4 are within normal limits, ruling out primary hypothyroidism. The patient has a valid advance directive naming his wife as proxy and preferring home care, superseding the son's demands.
Ruling out reversible causes (like thyroid dysfunction) and respecting ethical guidelines are mandatory before initiating new therapies.
3
Determine the optimal pharmacological management for the confirmed diagnosis.
Rivastigmine, a central acetylcholinesterase inhibitor, is selected.
Cholinesterase inhibitors are the first-line evidence-based treatment for the cognitive and behavioral symptoms (including hallucinations) of LBD. Antipsychotics must be avoided due to severe neuroleptic sensitivity.

Key Concept

Major neurocognitive disorder with Lewy bodies (LBD) presents with fluctuating cognition, visual hallucinations, and parkinsonism; cholinesterase inhibitors are the preferred initial treatment for cognitive and neuropsychiatric symptoms.
Estimated Time:1m 30s
Question 3375Question →

Match each patient's clinical presentation to the primary pathophysiological mechanism responsible for their psychiatric emergency or drug-induced toxicity.

Click a left item, then click its matching right item

Items

A 32-year-old man on the inpatient psychiatric unit develops a temperature of 40.0°C (104.0°F), profound 'lead-pipe' muscle rigidity, and diaphoresis three days after his haloperidol dosage was increased. Labs show a creatine kinase of 5,000 U/L.
A 24-year-old woman in the emergency department exhibits severe agitation, a temperature of 38.5°C (101.3°F), bilateral lower extremity hyperreflexia, and spontaneous ankle clonus after initiating phenelzine while still taking fluoxetine.
A 19-year-old man presents to the emergency department with acute, painful, and sustained upward deviation of his eyes and contraction of his neck muscles 48 hours after receiving an intramuscular injection of fluphenazine for acute psychosis.
A 45-year-old woman is brought to the emergency department obtunded with a heart rate of 120/min, dry flushed skin, mydriasis, and an ECG demonstrating sinus tachycardia with a QRS duration of 140 msec following an intentional drug overdose.
A 50-year-old man with bipolar disorder presents to the clinic with a new-onset coarse hand tremor, severe ataxia, confusion, and vomiting two weeks after his primary care physician started him on hydrochlorothiazide for hypertension.

Matches

Show answer & explanation

Answer

The clinical presentations match their pathophysiological mechanisms as follows: NMS is caused by D2 blockade; Serotonin Syndrome by 5-HT overactivation; Acute Dystonia by nigrostriatal cholinergic excess; TCA toxicity by sodium channel blockade and muscarinic antagonism; and Lithium toxicity by enhanced proximal tubule reabsorption.
Each psychiatric emergency requires matching the distinct clinical toxidrome to its underlying receptor or pharmacokinetic etiology. Neuroleptic Malignant Syndrome (characterized by lead-pipe rigidity and extreme hyperthermia) is driven by profound dopamine D2 receptor blockade. Serotonin Syndrome (presenting with hyperreflexia and ankle clonus) is caused by excess 5-HT receptor activation. Acute dystonia (manifesting as sustained muscle contractions like torticollis) results from a relative cholinergic excess in the nigrostriatal tract following D2 blockade. TCA toxicity (presenting with a widened QRS and severe anticholinergic signs) is characterized by fast sodium channel blockade in the myocardium. Finally, Lithium toxicity (presenting with coarse tremor and ataxia) is frequently precipitated by thiazide diuretics, which induce volume depletion and trigger a compensatory proximal tubule reabsorption of both sodium and lithium.

Step-by-Step Solution

1
Analyze each clinical vignette to diagnose the specific psychiatric emergency or drug-induced toxidrome.
Identified the following diagnoses: Patient 1 has Neuroleptic Malignant Syndrome (NMS), Patient 2 has Serotonin Syndrome, Patient 3 has Acute Dystonia, Patient 4 has Tricyclic Antidepressant (TCA) toxicity, and Patient 5 has Lithium toxicity.
Accurate pattern recognition of vital sign abnormalities, neuromuscular findings, and medication history is the first step in psychiatric emergency triage.
2
Differentiate between hyperthermic syndromes with overlapping features (NMS vs. Serotonin Syndrome).
Patient 1 exhibits lead-pipe rigidity pointing to NMS (dopamine-driven), whereas Patient 2 exhibits hyperreflexia and clonus pointing to Serotonin Syndrome (serotonin-driven).
Neuromuscular examination findings are the most reliable clinical way to distinguish between these two life-threatening medication-induced toxidromes.
3
Correlate the identified toxidromes with their underlying cellular, receptor-level, or pharmacokinetic mechanisms.
Matched NMS to D2 blockade, Serotonin Syndrome to 5-HT activation, Dystonia to cholinergic excess, TCA toxicity to sodium channel blockade, and Lithium toxicity to proximal tubule reabsorption.
Understanding the definitive pathophysiological mechanism is required to choose the correct targeted pharmacological reversal agents (e.g., bromocriptine for NMS, sodium bicarbonate for TCA overdose).

Key Concept

Psychiatric Emergencies and Toxidromes: Pathophysiology and Presentation
Question 3376Question →

Match each psychological therapy modality with its core clinical focus and primary indicated psychiatric condition.

Click a left item, then click its matching right item

Items

Dialectical behavioral therapy
Exposure and response prevention
Motivational interviewing
Interpersonal psychotherapy

Matches

Show answer & explanation

Answer

Dialectical behavioral therapy pairs with distress tolerance for borderline personality disorder. Exposure and response prevention pairs with graduated contact for obsessive-compulsive disorder. Motivational interviewing pairs with resolving ambivalence for substance use disorders. Interpersonal psychotherapy pairs with resolving role transitions for major depressive disorder.
Each psychological therapy has specific, evidence-based indications based on its underlying mechanism. Dialectical behavioral therapy targets the emotional dysregulation of borderline personality disorder. Exposure and response prevention breaks the cycle of obsessive-compulsive disorder. Motivational interviewing addresses the ambivalence common in substance use disorders. Interpersonal psychotherapy targets the relational stressors often underlying major depressive disorder.

Step-by-Step Solution

1
Evaluate the clinical focus of Dialectical behavioral therapy.
Identified as focusing on mindfulness and emotional regulation for borderline personality disorder.
This matches the core curriculum developed specifically for the volatile emotional states seen in borderline personality disorder.
2
Evaluate the clinical focus of Exposure and response prevention.
Identified as involving contact with feared stimuli while withholding rituals for obsessive-compulsive disorder.
This is the definitive mechanism by which the obsessive-compulsive cycle is broken.
3
Evaluate the clinical focus of Motivational interviewing.
Identified as a client-centered approach to resolving ambivalence for substance use disorders.
Patients with addictions often struggle with readiness to change, which this therapy directly targets.
4
Evaluate the clinical focus of Interpersonal psychotherapy.
Identified as resolving role transitions and grief for major depressive disorder.
This therapy conceptualizes depressive episodes as deeply intertwined with interpersonal stressors and transitions.

Key Concept

Indications and core mechanisms of evidence-based psychological therapies.
Question 3377Question →

A 29-year-old woman presents to the psychiatric clinic for evaluation of severe, pervasive anxiety, muscle tension, and sleep disturbance that have been present for the past 8 months. She constantly worries about her finances, her family's health, and her job security, which has severely impaired her daily functioning. Her past psychiatric history is significant for a depressive episode at age 22. At that time, she was prescribed fluoxetine, but within two weeks of starting the medication, she developed a markedly elevated mood, decreased need for sleep, and grandiosity, leading to hospitalization. Her symptoms resolved shortly after fluoxetine was discontinued. She is currently taking phenelzine for her anxiety, but she reports it is ineffective and she struggles with the dietary restrictions.

Recent laboratory tests, ordered by her primary care physician to investigate her fatigue, reveal the following:

TestResultReference Range
Thyroid-stimulating hormone (TSH)0.1 mU/L0.1 \text{ mU/L}0.5−5.0 mU/L0.5 - 5.0 \text{ mU/L}
Free thyroxine (T4)0.4 ng/dL0.4 \text{ ng/dL}0.9−1.7 ng/dL0.9 - 1.7 \text{ ng/dL}

She requests a new medication for her anxiety and asks what her laboratory results mean.

Which of the following are appropriate next steps in the management of this patient? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Initiate cognitive-behavioral therapy focused on worry exposure and relaxation techniques; Refer the patient for a pituitary MRI and comprehensive endocrinologic evaluation

Answer

The correct steps are to initiate cognitive-behavioral therapy and to refer the patient for a pituitary MRI and endocrinologic evaluation.
The patient's presentation of excessive worry, muscle tension, and sleep disturbance over 8 months is consistent with Generalized Anxiety Disorder (GAD). Because she has a history of antidepressant-induced mania, she is on the bipolar spectrum. Cognitive-behavioral therapy (CBT) is an excellent, safe, first-line treatment for GAD that does not carry the risk of inducing a manic episode. Additionally, her laboratory results (low TSH and low free T4) indicate central (secondary) hypothyroidism. The appropriate next step for this endocrine abnormality is further evaluation of the pituitary-hypothalamic axis, typically including a pituitary MRI and checking other anterior pituitary hormones, before initiating levothyroxine. Initiating levothyroxine blindly in central hypothyroidism can precipitate an adrenal crisis if concurrent secondary adrenal insufficiency is present.

Step-by-Step Solution

1
Analyze the psychiatric presentation and history.
The patient has symptoms of Generalized Anxiety Disorder (GAD). However, her history of fluoxetine-induced mania indicates underlying Bipolar I disorder.
Identifying the bipolar diathesis is critical to avoid prescribing antidepressant monotherapy, which can trigger mania.
2
Evaluate the current psychiatric medications and potential interactions.
The patient is taking phenelzine, an MAOI. Any switch to a serotonergic medication (like an SSRI) requires a strict 14-day washout period.
Concurrent use or insufficient washout between MAOIs and SSRIs can precipitate severe, potentially fatal serotonin syndrome.
3
Interpret the laboratory findings.
The patient has both a low TSH and a low free T4.
This pattern indicates central (secondary) hypothyroidism, implying a pituitary or hypothalamic issue, rather than primary hypothyroidism (which would have elevated TSH).
4
Select the appropriate management steps based on the findings.
CBT is a safe and effective first-line treatment for GAD in bipolar disorder. An endocrinologic evaluation and pituitary MRI are required to investigate the central hypothyroidism.
These steps address both her psychiatric and medical needs safely without risking mania or dangerous drug interactions.

Key Concept

Management of Generalized Anxiety Disorder in patients with bipolar disorder, MAOI pharmacological safety, and interpretation of central hypothyroidism labs.
Question 3378Question →

Parents bring their 1616-year-old son to the acute care clinic due to the sudden onset of profound lower extremity weakness. The patient states that his legs feel "like jelly" and he is unable to stand independently. Over the past several months, his parents have noted a significant decline in his academic performance, increased irritability, and a tendency to isolate himself in the family's poorly ventilated detached garage for hours. Vital signs are within normal limits. Physical examination reveals flaccid paralysis of the bilateral lower extremities with absent deep tendon reflexes. A well-demarcated, erythematous, scaling dermatitis is noted surrounding his mouth and nares. His breath emits a faint, sweet, chemical odor. Laboratory studies are obtained and reveal the following:

Laboratory testResultReference range
Sodium138 mEq/L138 \text{ mEq/L}136−145 mEq/L136-145 \text{ mEq/L}
Potassium1.8 mEq/L1.8 \text{ mEq/L}3.5−5.0 mEq/L3.5-5.0 \text{ mEq/L}
Chloride115 mEq/L115 \text{ mEq/L}95−105 mEq/L95-105 \text{ mEq/L}
Bicarbonate12 mEq/L12 \text{ mEq/L}22−28 mEq/L22-28 \text{ mEq/L}
Blood urea nitrogen14 mg/dL14 \text{ mg/dL}7−18 mg/dL7-18 \text{ mg/dL}
Creatinine0.9 mg/dL0.9 \text{ mg/dL}0.6−1.2 mg/dL0.6-1.2 \text{ mg/dL}

Which of the following is the most likely primary mechanism underlying this patient's clinical presentation and laboratory findings?

Show answer & explanation

Answer: Impaired hydrogen ion excretion in the distal renal tubule

Answer

Impaired hydrogen ion excretion in the distal renal tubule
The correct answer is impaired hydrogen ion excretion in the distal renal tubule. This patient's presentation of perioral dermatitis ('glue sniffer's rash'), sweet chemical odor, behavioral changes, and garage isolation is highly characteristic of inhalant abuse, specifically toluene. Toluene toxicity famously causes a Type 11 (distal) renal tubular acidosis (RTA) by impairing hydrogen ion excretion in the distal renal tubule. This primary defect leads to a normal anion gap metabolic acidosis (NAGMA) and severe urinary potassium wasting. The resulting profound hypokalemia manifests clinically as flaccid paralysis, areflexia, and severe muscle weakness.

Step-by-Step Solution

1
Calculate the serum anion gap to classify the metabolic acidosis.
Anion gap = Na - (Cl + HCO3) = 138 - (115 + 12) = 11 mEq/L.
Determining if the acidosis is a normal or high anion gap narrows the differential diagnosis for toxic ingestions and metabolic disturbances.
2
Identify the clinical syndrome based on the metabolic profile and physical exam findings.
The patient has a normal anion gap metabolic acidosis (NAGMA) with severe hypokalemia, flaccid paralysis, and a classic perioral "glue sniffer's rash".
Synthesizing the lab data (hypokalemia + NAGMA) with the unique dermatologic and behavioral clues points to a specific toxic etiology.
3
Determine the pathophysiologic mechanism of the suspected toxicity.
Toluene inhalation causes Type 1 renal tubular acidosis by impairing distal tubule hydrogen ion excretion.
Matching the toxin (toluene) to its physiological effect on the kidneys confirms the correct underlying mechanism.

Key Concept

Toluene inhalation (inhalant abuse) causes a Type 1 (distal) renal tubular acidosis, characterized by a normal anion gap metabolic acidosis and severe hypokalemia that can present with rapidly progressive flaccid paralysis.
Question 3379Question →

A 33-year-old woman is brought to the outpatient psychiatry clinic by her wife. The patient reports a 3-week history of profound sadness, overwhelming fatigue, increased appetite, and sleeping up to 14 hours a day. She states she has been unable to go to work because she "cannot concentrate on anything." Her medical history is significant for primary hypothyroidism diagnosed 5 years ago, for which she is prescribed levothyroxine. Laboratory tests obtained this morning show a thyroid-stimulating hormone (TSH) level of 1.5 mIU/L1.5 \text{ mIU/L} (normal: 0.4−4.0 mIU/L0.4-4.0 \text{ mIU/L}) and a free thyroxine (T4) level of 1.2 ng/dL1.2 \text{ ng/dL} (normal: 0.8−1.8 ng/dL0.8-1.8 \text{ ng/dL}).

Further psychiatric interview reveals that two years ago, the patient experienced a 10-day episode where she felt "on top of the world," required only 2 hours of sleep per night, started multiple simultaneous home renovation projects, and spoke so rapidly it was difficult to interrupt her. She was prescribed a medication at that time but discontinued it after a month. She currently takes no psychiatric medications.

Which of the following are appropriate pharmacological interventions for this patient's current episode? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Initiate quetiapine; Initiate lurasidone

Answer

The appropriate interventions are to initiate quetiapine and initiate lurasidone.
The patient's history of a manic episode (decreased need for sleep, grandiosity, pressured speech lasting over a week) paired with her current severe depressive episode confirms a diagnosis of Bipolar I Disorder, current episode depressed. The first-line pharmacological treatment for acute bipolar depression includes specific second-generation antipsychotics, notably quetiapine and lurasidone, which are highly effective and FDA-approved for this indication. These agents manage the depression without risking a manic switch.

Step-by-Step Solution

1
Diagnose the current psychiatric episode based on presenting symptoms.
The patient has 3 weeks of depressed mood, hypersomnia, fatigue, hyperphagia, and poor concentration, which meets the criteria for a major depressive episode.
Establishing the current affective state is necessary to guide acute pharmacological treatment.
2
Assess past psychiatric history to differentiate unipolar from bipolar depression.
The patient had a prior 10-day episode of grandiosity, decreased need for sleep, hyper-productivity, and pressured speech. This meets the criteria for a manic episode, establishing a diagnosis of Bipolar I Disorder.
The treatment for bipolar depression differs drastically from unipolar major depressive disorder, primarily regarding the use of antidepressants.
3
Evaluate laboratory results to rule out secondary causes of depressive symptoms.
The TSH and free T4 levels are normal, confirming that the depressive symptoms are psychiatric in origin and not due to undertreated hypothyroidism.
Medical mimics, such as hypothyroidism, must be ruled out before initiating psychotropic medications.
4
Select appropriate pharmacological therapies for Bipolar I depression.
First-line agents include specific atypical antipsychotics (quetiapine, lurasidone, cariprazine) or mood stabilizers (lithium, lamotrigine).
Antidepressant monotherapy must be strictly avoided in bipolar disorder due to the high risk of inducing mania.

Key Concept

Treatment of Acute Bipolar Depression
Estimated Time:1m 30s
Question 3380Question →

A 24-year-old woman is brought to the emergency department by her older sister due to increasingly erratic behavior. The patient has a history of major depressive disorder, for which she currently takes no medications. For the past two weeks, she has been sleeping only 2 hours a night, exhibiting pressured speech, and endorsing grand delusions that she is a highly-trained secret agent. Today, she told her sister, "I have to jump off the hospital roof tonight to prove my immortality to the agency." In the emergency department, the patient is highly agitated, pacing the room, and attempting to elope. She adamantly refuses voluntary admission and any medical treatment. The patient has a valid advance directive from a previous depressive episode that explicitly names her sister as her healthcare proxy. However, the patient's father arrives at the emergency department, states that psychiatric care is a "hoax," and demands to take his daughter home immediately. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Place the patient on an involuntary psychiatric hold

Answer

The most appropriate next step is to place the patient on an involuntary psychiatric hold to ensure her safety.
The correct action is to place the patient on an involuntary psychiatric hold. This patient is experiencing a severe manic episode with psychotic features (bipolar I disorder) and has expressed a clear, lethal plan to harm herself ("jump off the hospital roof... to prove my immortality"). Because she lacks decision-making capacity due to her psychosis and poses an imminent threat to her own life, she meets the universal criteria for involuntary psychiatric commitment. When a patient is an acute danger to themselves, emergency safety protocols and state laws supersede the wishes of family members, even legally appointed healthcare proxies. Therefore, the physician must legally and ethically detain the patient to provide life-saving psychiatric stabilization.

Step-by-Step Solution

1
Assess the patient's clinical presentation and risk of imminent harm.
The patient exhibits classic signs of acute mania with psychotic features and has a specific, lethal plan for self-harm (jumping off the roof).
Determining the safety risk is the absolute first priority in any acute psychiatric emergency.
2
Evaluate the patient's capacity and willingness to accept psychiatric treatment.
The patient lacks insight into her illness and adamantly refuses voluntary admission or treatment.
When a patient lacks capacity and refuses life-saving care, legal frameworks for involuntary treatment must be considered.
3
Determine the appropriate legal and ethical intervention regarding surrogate decision-makers.
Because the patient is an imminent danger to herself, state involuntary hold laws supersede all surrogate or family preferences.
Even though a healthcare proxy exists, emergency involuntary commitment is mandated when the threshold for self-harm is met, making discharge to any family member inappropriate.

Key Concept

Criteria for involuntary psychiatric holds and management of acute mania with safety risks
Estimated Time:1m 15s
PreviousPage 169 / 414Next
All practice questions — USMLE Step 2 CK | Examkin